The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call
The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, has scheduled its second quarter 2025 financial results announcement for Wednesday, August 13, 2025, after market close.
The company will host a conference call at 5:00 p.m. Eastern Time on the same day. Investors can join via phone (1-877-407-0789 for domestic, 1-201-689-8562 for international) or webcast through TOI's Investor Relations website. A replay will be available until August 20, 2025, using passcode 13754165.
L'Istituto di Oncologia (NASDAQ: TOI), un gruppo oncologico di riferimento negli Stati Uniti basato sul valore, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per mercoledì 13 agosto 2025, dopo la chiusura del mercato.
La società terrà una conference call alle 17:00 ora della costa orientale lo stesso giorno. Gli investitori potranno partecipare telefonicamente (1-877-407-0789 per chiamate nazionali, 1-201-689-8562 per chiamate internazionali) o tramite webcast sul sito web delle Relazioni con gli Investitori di TOI. Una registrazione sarà disponibile fino al 20 agosto 2025, utilizzando il codice di accesso 13754165.
El Instituto de Oncología (NASDAQ: TOI), un grupo oncológico líder basado en el valor en Estados Unidos, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el miércoles 13 de agosto de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 5:00 p.m., hora del Este ese mismo día. Los inversionistas pueden unirse por teléfono (1-877-407-0789 para llamadas nacionales, 1-201-689-8562 para internacionales) o por webcast a través del sitio web de Relaciones con Inversionistas de TOI. Una repetición estará disponible hasta el 20 de agosto de 2025, usando el código de acceso 13754165.
온콜로지 연구소(NASDAQ: TOI)는 미국의 선도적인 가치 기반 종양학 그룹으로, 2025년 2분기 재무 결과를 2025년 8월 13일 수요일 장 마감 후에 발표할 예정입니다.
회사는 같은 날 동부 표준시 오후 5시에 컨퍼런스 콜을 진행합니다. 투자자들은 국내 전화(1-877-407-0789), 국제 전화(1-201-689-8562) 또는 TOI 투자자 관계 웹사이트를 통해 웹캐스트로 참여할 수 있습니다. 재청취는 2025년 8월 20일까지 가능하며, 접속 암호는 13754165입니다.
Institut d'Oncologie (NASDAQ : TOI), un groupe oncologique de premier plan axé sur la valeur aux États-Unis, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le mercredi 13 août 2025, après la clôture des marchés.
L'entreprise tiendra une conférence téléphonique à 17h00, heure de l'Est le même jour. Les investisseurs pourront participer par téléphone (1-877-407-0789 pour les appels nationaux, 1-201-689-8562 pour les appels internationaux) ou via un webcast sur le site des relations investisseurs de TOI. Un replay sera disponible jusqu'au 20 août 2025, avec le code d'accès 13754165.
Das Oncology Institute (NASDAQ: TOI), eine führende wertorientierte Onkologie-Gruppe in den Vereinigten Staaten, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Mittwoch, den 13. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten. Investoren können telefonisch teilnehmen (1-877-407-0789 für Inlandsanrufe, 1-201-689-8562 für internationale Anrufe) oder über einen Webcast auf der Investor-Relations-Website von TOI. Eine Aufzeichnung ist bis zum 20. August 2025 mit dem Zugangscode 13754165 verfügbar.
- None.
- None.
CERRITOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2025 financial results after the market close on Wednesday, August 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13754165. The replay will be available until Wednesday, August 20, 2025.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information, visit www.theoncologyinstitute.com
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
When will The Oncology Institute (TOI) release Q2 2025 earnings?
How can investors access TOI's Q2 2025 earnings conference call?
What is the replay information for TOI's Q2 2025 earnings call?
Where can I find the webcast for The Oncology Institute's Q2 earnings call?
